Literature DB >> 1313053

Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus.

J T Wang1, T H Wang, J C Sheu, S M Lin, J T Lin, D S Chen.   

Abstract

Blood samples from 11 patients with posttransfusion hepatitis C virus infection were collected. Each sample was divided into three fractions to obtain sera, sodium-citrated plasma, and heparinized plasma and then tested for HCV RNA by a nested polymerase chain reaction (PCR). Of them, eight sodium-citrated plasma samples, seven serum samples, and no heparinized plasma samples were PCR positive. Eight PCR-positive sodium-citrated plasma samples were exposed to different physical conditions and semiquantified for HCV RNA after serial dilutions. Samples stored at -70 degrees C showed the best preservation of HCV RNA, and storage at the other conditions resulted in only minimal loss of the PCR signal. Therefore, serum or sodium-citrated plasma specimens are satisfactory for detecting HCV RNA by PCR, but heparinized blood specimens are not.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313053      PMCID: PMC265150          DOI: 10.1128/jcm.30.3.750-753.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Interference of heparin with the polymerase chain reaction.

Authors:  E Beutler; T Gelbart; W Kuhl
Journal:  Biotechniques       Date:  1990-08       Impact factor: 1.993

2.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

3.  Early events in hepatitis C virus infection of chimpanzees.

Authors:  Y K Shimizu; A J Weiner; J Rosenblatt; D C Wong; M Shapiro; T Popkin; M Houghton; H J Alter; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase.

Authors:  P P Ulrich; J M Romeo; P K Lane; I Kelly; L J Daniel; G N Vyas
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.

Authors:  C L Van der Poel; H T Cuypers; H W Reesink; A J Weiner; S Quan; R Di Nello; J J Van Boven; I Winkel; D Mulder-Folkerts; P J Exel-Oehlers
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

6.  Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.

Authors:  D S Chen; G C Kuo; J L Sung; M Y Lai; J C Sheu; P J Chen; P M Yang; H M Hsu; M H Chang; C J Chen
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

7.  Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen.

Authors:  J T Wang; T H Wang; J C Sheu; L N Shih; J T Lin; D S Chen
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

8.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

9.  Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity.

Authors:  J A Garson; R S Tedder; M Briggs; P Tuke; J A Glazebrook; A Trute; D Parker; J A Barbara; M Contreras; S Aloysius
Journal:  Lancet       Date:  1990-06-16       Impact factor: 79.321

10.  Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region.

Authors:  H Okamoto; S Okada; Y Sugiyama; T Tanaka; Y Sugai; Y Akahane; A Machida; S Mishiro; H Yoshizawa; Y Miyakawa
Journal:  Jpn J Exp Med       Date:  1990-08
View more
  29 in total

1.  Purification and characterization of PCR-inhibitory components in blood cells.

Authors:  W A Al-Soud; P Rådström
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Assessment of hepatitis B virus DNA stability in serum by the Chiron Quantiplex branched-DNA assay.

Authors:  M Krajden; L Comanor; O Rifkin; A Grigoriew; J M Minor; G F Kapke
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Stability of hepatitis C virus RNA in blood samples by TaqMan real-time PCR.

Authors:  Kenan Sener; Mehmet Yapar; Orhan Bedir; Cem Gül; Omer Coskun; Ayhan Kubar
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

4.  Detection of Helicobacter pylori in gastric biopsy tissue by polymerase chain reaction.

Authors:  J T Wang; J T Lin; J C Sheu; J C Yang; D S Chen; T H Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

5.  Detection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube sera.

Authors:  M Krajden; J Zhao; C Bourke; V Scalia; P Gill; W Lau
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

6.  Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus.

Authors:  H T Cuypers; D Bresters; I N Winkel; H W Reesink; A J Weiner; M Houghton; C L van der Poel; P N Lelie
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

7.  Standardized nested polymerase chain reaction-based assay for detection of human immunodeficiency virus type 1 DNA in whole blood lysates.

Authors:  S Sauvaigo; V Barlet; N Guettari; P Innocenti; F Parmentier; C Bastard; J M Seigneurin; J C Chermann; R Teoule; J Marchand
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

8.  Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections.

Authors:  K E Sherman; J O'Brien; A G Gutierrez; S Harrison; M Urdea; P Neuwald; J Wilber
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

9.  Detection of mouse mast cell-associated protease mRNA. Heparinase treatment greatly improves RT-PCR of tissues containing mast cell heparin.

Authors:  M Tsai; M Miyamoto; S Y Tam; Z S Wang; S J Galli
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

10.  Hepatitis B virus persistence after recovery from acute viral hepatitis.

Authors:  T I Michalak; C Pasquinelli; S Guilhot; F V Chisari
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.